Alpha Preclinical

Alpha Preclinical (Alpha) formed in 2020 and is a US owned company. We are a discovery preclinical research service company designed to address the rapid and expansive growth demand of the discovery preclinical research sector. The life-science research community is being challenged to accelerate therapies into the market with better operational efficiency. Outsourcing preclinical research needs, allows companies to focus on their core competencies and reduce time to market. Alpha bridges our clients needs to reach the clinic and harnessing our expertise using a personalized interface approach. Our goal is to strategically partner with our clients by reliably providing well-executed...

- preclinical studies - animal models (mice,rats,rabbits,pigs) - pharmacokinetics/pharmacodynamics (pk/pd) studies - diabetes research - autoimmune disorder research - cancer research - gene therapy - vaccine development - obesity research - central nervous system (cns) disorders - drug efficacy and safety testing - toxicology studies - biomarker discovery - customized research solutions - regulatory compliance

Alpha preclinical operates in the Biotechnology research industry.

Alpha preclinical's revenue is 11m - 100m

Alpha preclinical has 11 - 50 employees.